AU3760100A - Immunostimulatory nucleic acids and antigens - Google Patents

Immunostimulatory nucleic acids and antigens

Info

Publication number
AU3760100A
AU3760100A AU37601/00A AU3760100A AU3760100A AU 3760100 A AU3760100 A AU 3760100A AU 37601/00 A AU37601/00 A AU 37601/00A AU 3760100 A AU3760100 A AU 3760100A AU 3760100 A AU3760100 A AU 3760100A
Authority
AU
Australia
Prior art keywords
antigens
nucleic acids
immunostimulatory nucleic
immunostimulatory
acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37601/00A
Inventor
Michael J. Caplan
Howard B. Sosin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seer Pharmaceuticals LLC
Original Assignee
Panacea Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Pharmaceuticals LLC filed Critical Panacea Pharmaceuticals LLC
Publication of AU3760100A publication Critical patent/AU3760100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/38—Antigens from snakes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU37601/00A 1999-03-16 2000-03-16 Immunostimulatory nucleic acids and antigens Abandoned AU3760100A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12459599P 1999-03-16 1999-03-16
US60124595 1999-03-16
US12507199P 1999-03-17 1999-03-17
US60125071 1999-03-17
PCT/US2000/007213 WO2000054803A2 (en) 1999-03-16 2000-03-16 Immunostimulatory nucleic acids and antigens

Publications (1)

Publication Number Publication Date
AU3760100A true AU3760100A (en) 2000-10-04

Family

ID=26822754

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37601/00A Abandoned AU3760100A (en) 1999-03-16 2000-03-16 Immunostimulatory nucleic acids and antigens

Country Status (2)

Country Link
AU (1) AU3760100A (en)
WO (1) WO2000054803A2 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US7935675B1 (en) 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6589940B1 (en) 1997-06-06 2003-07-08 Dynavax Technologies Corporation Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
NZ508927A (en) 1998-05-22 2003-12-19 Ottawa Health Research Inst Methods and products for inducing mucosal immunity
EP2204186B1 (en) 1999-02-17 2016-04-06 CSL Limited Immunogenic complexes and methods relating thereto
DE60041335D1 (en) 1999-08-19 2009-02-26 Dynavax Tech Corp METHOD FOR MODULATING AN IMMUNE RESPONSE WITH IMMUNOSTIMULATING SEQUENCES AND COMPOSITIONS THEREFOR
CN101543507A (en) * 1999-09-25 2009-09-30 衣阿华大学研究基金会 Immunostimulatory nucleic acids
AU2065801A (en) * 1999-12-06 2001-06-12 Panacea Pharmaceuticals, Llc Passive desensitization
US7129222B2 (en) 2000-03-10 2006-10-31 Dynavax Technologies Corporation Immunomodulatory formulations and methods for use thereof
US20030129251A1 (en) 2000-03-10 2003-07-10 Gary Van Nest Biodegradable immunomodulatory formulations and methods for use thereof
AU2001219510B2 (en) * 2000-04-06 2007-06-14 Allertein Therapeutics, Llc Microbial delivery system
ATE471374T1 (en) 2000-12-27 2010-07-15 Dynavax Tech Corp IMMUNOMODULATORY POLYNUCLEOTIDES AND METHOD FOR USE THEREOF
CA2451974C (en) 2001-06-21 2014-10-14 Karen L. Fearon Chimeric immunomodulatory compounds and methods of using the same
WO2003014316A2 (en) 2001-08-07 2003-02-20 Dynavax Technologies Corporation Immunomodulatory compositions, formulations, and methods for use thereof
DE60234375D1 (en) 2001-09-14 2009-12-24 Cytos Biotechnology Ag PACKAGING IMMUNSTIMULATING CpG IN VIRUS LIKE PARTICLES: PREPARATION METHOD AND USE
US7741297B2 (en) 2002-02-04 2010-06-22 Oncothyreon Inc. Immunostimulatory, covalently lipidated oligonucleotides
US20040053880A1 (en) 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7807803B2 (en) 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
CN1753687A (en) 2002-10-29 2006-03-29 科勒制药集团股份有限公司 Use of cpg oligonucleotides in the treatment of hepatitis c virus infection
US7956043B2 (en) 2002-12-11 2011-06-07 Coley Pharmaceutical Group, Inc. 5′ CpG nucleic acids and methods of use
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
EP1575977B1 (en) 2002-12-23 2009-09-09 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
JP2007509983A (en) * 2003-10-30 2007-04-19 コーリー ファーマシューティカル ゲーエムベーハー C-class oligonucleotide analogs with enhanced immune stimulation
AU2005252268B2 (en) * 2004-06-10 2012-06-28 Aravax Pty Limited Novel immunointeractive molecules and uses thereof
US8057800B2 (en) * 2004-06-10 2011-11-15 Circassia Limited Immunointeractive molecules and uses thereof
WO2007068747A1 (en) 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
KR101552227B1 (en) 2006-06-12 2015-09-10 사이토스 바이오테크놀로지 아게 - processes for packaging oligonucleotides into virus-like particles of rna bacteriophages
NZ575437A (en) 2006-09-27 2012-02-24 Coley Pharm Gmbh Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
CN105120894B (en) 2012-10-30 2019-02-15 阿拉沃克斯有限公司 Novel Immunization therapy molecule and its purposes
EP3760223A1 (en) 2013-04-03 2021-01-06 N-Fold Llc Nanoparticle composition for desensitizing a subject to peanut allergens
RU2689552C2 (en) 2013-09-25 2019-05-28 Аравакс Пти Лтд Novel immunotherapeutic composition and use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338297A (en) * 1980-02-19 1982-07-06 Michael Jacob G Polypeptide active pollen immunosuppressant fraction
US5804201A (en) * 1996-03-11 1998-09-08 The Rockefeller University Immunomodulatory peptides of vespid antigen 5
DK1003850T3 (en) * 1997-06-06 2009-09-07 Univ California Inhibitors of DNA immunostimulatory sequence activity

Also Published As

Publication number Publication date
WO2000054803A3 (en) 2001-01-11
WO2000054803A2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
AU3760100A (en) Immunostimulatory nucleic acids and antigens
IL148843A0 (en) Immunostimulatory nucleic acids
AU7398200A (en) Chlamydia antigens and corresponding dna fragments and uses thereof
AU2001249251A1 (en) Novel nucleic acids and polypeptides
AU2001243142A1 (en) Novel nucleic acids and polypeptides
AU2001234944A1 (en) Novel nucleic acids and polypeptides
AU2001290548A1 (en) Novel nucleic acids and polypeptides
AU2001245280A1 (en) Novel nucleic acids and polypeptides
AU2001233041A1 (en) Novel nucleic acids and polypeptides
AU2001238347A1 (en) Novel nucleic acids and polypeptides
AU2001296235A1 (en) Novel nucleic acids and polypeptides
AU2001263006A1 (en) Novel nucleic acids and polypeptides
AU2002246502A1 (en) Nucleic acids and polypeptides
AU2001233017A1 (en) Novel nucleic acids and polypeptides
AU2001292561A1 (en) Nucleic acids and polypeptides
AU2001269039A1 (en) Immobilized nucleic acids and uses thereof
AU2001250872A1 (en) Novel nucleic acids and polypeptides
AU2138501A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
WO2002016439A8 (en) Novel nucleic acids and polypeptides
AU5245900A (en) Novel protein and dna thereof
AU2138601A (en) Chlamydia antigens and corresponding DNA fragments and uses thereof
AU3511100A (en) Novel nucleic acids and polypeptides
AU2001263005A1 (en) Novel nucleic acids and polypeptides
AU2225401A (en) Novel protein and dna thereof
AU6601098A (en) Vaccine and assay

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase